MedPath

Tobrex

Tobrextobramycin ophthalmicointment 0.3%

Approved
Approval ID

3d4be22b-7a8c-4247-ac35-143611342de1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tobramycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-458
Application NumberNDA050555
Product Classification
M
Marketing Category
C73594
G
Generic Name
tobramycin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 19, 2006
FDA Product Classification

INGREDIENTS (4)

tobramycinActive
Quantity: 3 mg in 1 g
Code: VZ8RRZ51VK
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
chlorobutanolInactive
Quantity: 5 mg in 1 g
Code: HM4YQM8WRC
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tobrex - FDA Drug Approval Details